Development and implementation of medication-related clinical rules for obstetrics, gynaecology, and paediatric outpatientsQuanyao Chen, Luwei Wang, Min Lin, Weida Chen, Wen Wu, Yao Chen
6 May 2022
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case seriesCarlos Guzmán Cordero, Maria Saez-Torres de Vicente
19 December 2022
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testingNicole Schönenberger, Carla Meyer-Massetti, Silvina Bravo
14 October 2022
Classification of non-antineoplastic intravenously administered drugs according to their toxicity risk: the path towards safe drug administrationTeresa Giménez Poderós, Juan José Fernández Cabero, Marta Valero Domínguez
19 May 2022
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot studyStephanie Heinemann, Jonas Klemperer, Eva Hummers, Roland Nau, Wolfgang Himmel
22 June 2022
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vialsMona Abdel-Tawab, Markus Waßmuth, Florian Gegenfurtner, Andrea Hawe, Jan H Schefe, Anke M Strunz, Joachim Wübert
19 July 2022
Analysing electronic prescribing data to detect potential undocumented adverse reactions to medicationsBen Logan, Andrew Hill
30 March 2022
Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapiesAndrea Rodríguez Esquíroz, Amaya Arrondo Velasco, Amaia Egüés Lugea, Maite Sarobe Carricas
28 February 2022
Managing the risk of shortages and medication errors with curares during the COVID-19 pandemic: a hospital pharmacy experienceXavier Bohand, Dominique Jordan, Frederique Dubois
31 March 2021
The potential for deprescribing in a palliative oncology patient population: a cross-sectional studyLisanne N van Merendonk, Bas J M Peters, Julia E Möhlmann, Cornelis B Hunting, Elisabeth A Kastelijn, Marcel P H van den Broek
23 February 2022
